9MW3011 placebo

DRUG2 trials

Sponsors

Mabwell (Shanghai) Bioscience Co., Ltd.

Conditions

Beta-ThalassemiaHealthy

Phase 1

Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject

CompletedNCT06389942

Mabwell (Shanghai) Bioscience Co., Ltd.Healthy

Start: 2023-03-10End: 2024-05-31Updated: 2024-12-27

A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia

RecruitingNCT06772766

Mabwell (Shanghai) Bioscience Co., Ltd.Beta-Thalassemia

Start: 2024-12-30End: 2026-10-31Target: 40Updated: 2025-01-14